{"address1": "701 Veterans Circle", "city": "Warminster", "state": "PA", "zip": "18974", "country": "United States", "phone": "267 469 0914", "website": "https://www.arbutusbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of imdusiran (AB-729), a proprietary subcutaneously-delivered RNAi therapeutic product candidate that suppresses all HBV antigens, including HBsAg expression. The company's research and development programs include AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune system; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has licensing agreements with Gritstone Oncology, Inc; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Barinthus Biotherapeutics plc to evaluate VTP-300. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.", "fullTimeEmployees": 44, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lindsay  Androski J.D., M.B.A.", "age": 52, "title": "President, CEO & Chairman", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tuan  Nguyen", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa M. Caperelli", "title": "Vice President of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shannon  Briscoe SPHR", "title": "Vice President of Human Resources", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C.", "age": 73, "title": "Corporate Secretary", "yearBorn": 1951, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 10, "compensationRisk": 7, "shareHolderRightsRisk": 9, "overallRisk": 10, "governanceEpochDate": 1743465600, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.49, "open": 3.46, "dayLow": 3.41, "dayHigh": 3.6, "regularMarketPreviousClose": 3.49, "regularMarketOpen": 3.46, "regularMarketDayLow": 3.41, "regularMarketDayHigh": 3.6, "payoutRatio": 0.0, "beta": 1.926, "forwardPE": -10.235294, "volume": 1358381, "regularMarketVolume": 1358381, "averageVolume": 892826, "averageVolume10days": 1099980, "averageDailyVolume10Day": 1099980, "bid": 3.44, "ask": 3.54, "bidSize": 1, "askSize": 2, "marketCap": 666350400, "fiftyTwoWeekLow": 2.3, "fiftyTwoWeekHigh": 4.72, "priceToSalesTrailing12Months": 107.98094, "fiftyDayAverage": 3.3462, "twoHundredDayAverage": 3.5908, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 549846080, "profitMargins": 0.0, "floatShares": 136309001, "sharesOutstanding": 191480000, "sharesShort": 9574515, "sharesShortPriorMonth": 7212196, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0505, "heldPercentInsiders": 0.22027999, "heldPercentInstitutions": 0.54771, "shortRatio": 8.76, "shortPercentOfFloat": 0.0641, "impliedSharesOutstanding": 191754000, "bookValue": 0.513, "priceToBook": 6.7836256, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -69920000, "trailingEps": -0.38, "forwardEps": -0.34, "lastSplitFactor": "1:5", "lastSplitDate": 1288828800, "enterpriseToRevenue": 89.102, "enterpriseToEbitda": -7.604, "52WeekChange": 0.1917808, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 3.48, "targetHighPrice": 6.972765, "targetLowPrice": 3.997905, "targetMeanPrice": 5.2391763, "targetMedianPrice": 4.9930167, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 122623000, "totalCashPerShare": 0.64, "ebitda": -72314000, "totalDebt": 6118000, "quickRatio": 8.025, "currentRatio": 8.152, "totalRevenue": 6171000, "debtToEquity": 6.284, "revenuePerShare": 0.033, "returnOnAssets": -0.33363, "returnOnEquity": -0.68757004, "grossProfits": -47866000, "freeCashflow": -41556376, "operatingCashflow": -64850000, "revenueGrowth": -0.266, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -9.95426, "financialCurrency": "USD", "symbol": "ABUS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Arbutus Biopharma Corporation", "longName": "Arbutus Biopharma Corporation", "regularMarketChange": -0.00999999, "regularMarketDayRange": "3.41 - 3.6", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 892826, "fiftyTwoWeekLowChange": 1.1800001, "fiftyTwoWeekLowChangePercent": 0.5130435, "fiftyTwoWeekRange": "2.3 - 4.72", "fiftyTwoWeekHighChange": -1.2399998, "fiftyTwoWeekHighChangePercent": -0.26271182, "fiftyTwoWeekChangePercent": 19.178082, "earningsTimestamp": 1743075000, "earningsTimestampStart": 1746012600, "earningsTimestampEnd": 1746444600, "earningsCallTimestampStart": 1730900700, "earningsCallTimestampEnd": 1730900700, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.38, "epsForward": -0.34, "epsCurrentYear": -0.32525, "priceEpsCurrentYear": -10.699462, "fiftyDayAverageChange": 0.13380003, "fiftyDayAverageChangePercent": 0.039985664, "twoHundredDayAverageChange": -0.11080003, "twoHundredDayAverageChangePercent": -0.030856641, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1185456600000, "regularMarketChangePercent": -0.28653267, "regularMarketPrice": 3.48, "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_34160168", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "displayName": "Arbutus Biopharma", "trailingPegRatio": null}